Search Ontology:
ChEBI
alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-yl group
- Term ID
- CHEBI:88162
- Synonyms
-
- 6-deoxy-alpha-L-galactopyranosyl-(1->3)-[6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-beta-D-glucopyranosyl
- alpha-Fuc-(1->2)-beta-Gal-(1->4)-[alpha-Fuc-(1->3)]-beta-GlcNAc-yl
- alpha-Fuc-(1->2)-beta-Gal-(1->4)-[alpha-Fuc-(1->3)]-beta-GlcNAc-yl group
- alpha-L-fucopyranosyl-(1->3)-[alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-beta-D-glucopyranosyl
- Le(y)
- Lewis Y
- Lewis Y tetrasaccharide
- Definition
- A branched tetrasaccharide glucosaminyl group consisting of N-acetylbeta-D-glucosaminyl residue having a fucosyl residue attached at the 3-position via a beta-linkage and an alpha-fucosyl-(1->2)-galactosyl disaccharide unit attached at the 4-position, also via a beta-linkage.
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- is_substituent_group_from
-
Phenotype
Phenotype resulting from alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-yl group
Phenotype where environments contain alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-yl group
Phenotype modified by environments containing alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-yl group
Human Disease Model